Status:

RECRUITING

The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities

Lead Sponsor:

Fujian Medical University Union Hospital

Conditions:

Soft Tissue Sarcomas

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

For localized soft tissue sarcomas (STS) of the extremities, limb-sparing or conservative surgery with perioperative radiotherapy (RT) is the standard of care. However, several challenges persist. Not...

Eligibility Criteria

Inclusion

  • Primary soft tissue sarcoma of the extremities, with one of the following characteristics: high grade, ≥5cm or deep tumor, the need for neoadjuvant radiotherapy was determined after multidisciplinary consultation.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2.
  • Age 18-75 years old.
  • Histologic diagnosis of soft tissue sarcoma.
  • Can tolerate radiotherapy and AI regimen treatment.
  • The function of major organs is normal.

Exclusion

  • There were no patients with gross tumors after unplanned mass resection in another hospital.
  • Patients with other comorbidities cannot use AI chemotherapy: drug allergy, active bleeding, ulcers, intestinal perforation, intestinal obstruction, uncontrollable hypertension, grade III-IV cardiac insufficiency (NYHA standards), severe liver and renal insufficiency ( Level IV) etc.
  • New malignant tumors within 5 years (except cervical carcinoma in situ or early cutaneous basal cell carcinoma).
  • Pathological types: nonpleomorphic rhabdomyosarcoma, Ewing sarcoma.
  • Soft tissue sarcoma curable by simple expansion.
  • Previous history of radiotherapy to the same site.
  • Combined with distant metastasis (M1) or lymph node metastasis (N1).
  • Have other severe medical comorbidities that preclude surgery or participation in the study.
  • Previous exposure to chemotherapy.

Key Trial Info

Start Date :

May 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT06593899

Start Date

May 1 2024

End Date

July 1 2026

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fujian Medical University Union Hospital

Fuzhou, Fujian, China, 350001